Recombinant PDCD1 (Spartalizumab Biosimilar) antibody

Catalog No. ABIN7598003

The Humanized Chimeric anti-PDCD1 (Spartalizumab Biosimilar) antibody (ABIN7598003) specifically detects PDCD1 (Spartalizumab Biosimilar). The antibody is reactive with Human samples.

Quick Overview for Recombinant PDCD1 (Spartalizumab Biosimilar) antibody (ABIN7598003)

Target: PDCD1 (Spartalizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This PDCD1 (Spartalizumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-PDCD1 (Spartalizumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Spartalizumab Biosimilar Antibody

Specificity: Programmed cell death protein 1, Protein PD-1, hPD-1, PD1, PDCD1, CD279

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG4 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for PDCD1 (Spartalizumab Biosimilar)

Target: PDCD1 (Spartalizumab Biosimilar)

Alternative Name: Spartalizumab Biosimilar

Target Type: Biosimilar

Background: Programmed cell death protein 1, Protein PD-1, hPD-1, PD1, PDCD1, CD279

UniProt: Q15116

CAS-No: 1935694-88-4